NEUROVISION MEDICAL PRODUCTS, INC. v. NUVASIVE INC., 09-CV-6988 DSF (JEMx). (2014)
Court: District Court, C.D. California
Number: infdco20140904769
Visitors: 32
Filed: Aug. 25, 2014
Latest Update: Aug. 25, 2014
Summary: PERMANENT INJUNCTION DALE S. FISCHER, District Judge. For the reasons stated in the Court's August 5, 2014 Order GRANTING Plaintiff's Motion for Permanent Injunction and Cancellation of Trademark Registrations, and based on the parties' Stipulation re: Permanent Injunction, the Court hereby Orders the following: NuVasive and each of its officers, agents, servants and employees, and all those persons in active concert or participation with them are hereby forever enjoined from using the mark N
Summary: PERMANENT INJUNCTION DALE S. FISCHER, District Judge. For the reasons stated in the Court's August 5, 2014 Order GRANTING Plaintiff's Motion for Permanent Injunction and Cancellation of Trademark Registrations, and based on the parties' Stipulation re: Permanent Injunction, the Court hereby Orders the following: NuVasive and each of its officers, agents, servants and employees, and all those persons in active concert or participation with them are hereby forever enjoined from using the mark NE..
More
PERMANENT INJUNCTION
DALE S. FISCHER, District Judge.
For the reasons stated in the Court's August 5, 2014 Order GRANTING Plaintiff's Motion for Permanent Injunction and Cancellation of Trademark Registrations, and based on the parties' Stipulation re: Permanent Injunction, the Court hereby Orders the following:
NuVasive and each of its officers, agents, servants and employees, and all those persons in active concert or participation with them are hereby forever enjoined from using the mark NEUROVISION in the sale, offering for sale, distribution, lending, marketing or advertising of medical devices or related merchandise and services at any locality in the United States, provided, however, that the following shall not be considered a violation of this injunction:
º Use of or reference to the NEUROVISION mark for truthful informational purposes with investors and regulatory agencies, including without limitation, the Securities and Exchange Commission or FDA, to refer to historic products, historic product sales, and/or this lawsuit;
º In response to a customer inquiry, NuVasive can truthfully explain that it formerly marketed products under the name NEUROVISION.
IT IS SO ORDERED.
Source: Leagle
